A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1.

Cells · 2024 · PMC11011525 · PMID 38607071

Europe PMC DOI

hedged sentence

0.1900

closest p · 3.8× alpha

0.1900

boldest claim

The sentences

showed a trendp = 0.19not close (p > 0.1)

Lower Mcl-1 expression showed a trend towards improved OS ( Figure 3 H; p = 0.19) and correlated significantly with disease-free survival (DFS) ( Figure 3 K; p = 0.03).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.